315
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Exposure to 1,3-Butadiene in the U.S. Population: National Health and Nutrition Examination Survey 2011–2016

, , , , & ORCID Icon
Pages 371-383 | Received 12 Nov 2020, Accepted 09 Mar 2021, Published online: 08 Apr 2021

References

  • Abrantes, S., et al., 2000. Headspace gas chromatographic determination of 1,3-butadiene in simulated saliva. Journal of AOAC international, 83 (4), 929–932.
  • Ahuja, J.K., et al., 2013. USDA food and nutrient databases provide the infrastructure for food and nutrition research, policy, and practice. The journal of nutrition, 143 (2), 241S–249s.
  • Albertini, R.J., et al., 2003. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. Research report (health effects institute), 116, 1–141, discussion 143–162.
  • Alwis, K.U., et al., 2012. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Analytica chimica acta, 750, 152–160.
  • ATSDR 2012., Toxicological profile for 1,3-butadiene. Atlanta, GA: U.S. Department of Health and Human Services.
  • Bagchi, P., et al., 2018. Crotonaldehyde exposure in U.S. tobacco smokers and nonsmokers: NHANES 2005-2006 and 2011-2012. Environmental research., 163, 1–9.
  • Barr, D.B., et al., 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environmental health perspectives, 113 (2), 192–200.
  • Bearer, C.F., 1995. How are children different from adults? Environmental health perspectives, 103 (Suppl 6), 7–12.
  • Bechtold, W.E., et al., 1994. Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans. Toxicology and applied pharmacology, 127 (1), 44–49.
  • Benowitz, N.L., 1996. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic reviews, 18 (2), 188–204.
  • Biren, C., et al., 2020. Isoprene exposure in the United States based on urinary IPM3: NHANES 2015–2016. Environmental science & technology, 54 (4), 2370–2378.
  • Boldry, E.J., et al., 2017. Genetic determinants of 1,3-butadiene metabolism and detoxification in three populations of smokers with different risks of lung cancer. Cancer epidemiology biomarkers & prevention, 26 (7), 1034–1042.
  • Bond, J.A., et al., 1987. Species differences in the distribution of inhaled butadiene in tissues. American industrial hygiene association journal, 48 (10), 867–872.
  • Brunnemann, K.D., et al., 1989. Determination of benzene, toluene and 1,3-butadiene in cigarette smoke by GC-MDS. Experimental pathology, 37 (1–4), 108–113.
  • Capella, K.M., et al., 2019. Ethylbenzene and styrene exposure in the United States based on urinary mandelic acid and phenylglyoxylic acid: NHANES 2005–2006 and 2011–2012. Environmental research, 171, 101–110.
  • Carmella, S.G., et al., 2009. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chemical research in toxicology, 22 (4), 734–741.
  • CDC, 2010. Vital signs: nonsmokers’ exposure to secondhand smoke – United States, 1999–2008. Morbidity and mortality weekly report 2010, 59, 1141–1146.
  • CDC 2011-2017., National Health and Nutrition Examination Survey (NHANES). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS).
  • CDC 2014., Best Practices for Comprehensive Tobacco Control Programs–2014. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  • Chiang, W.C., et al., 2015. Fast and simple screening for the simultaneous analysis of seven metabolites derived from five volatile organic compounds in human urine using on-line solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry. Talanta, 132, 469–478.
  • Creamer, M.R., et al., 2019. Tobacco product use and cessation indicators among adults – United States, 2018. MMWR. Morbidity and mortality weekly report, 68 (45), 1013–1019.
  • Csanady, G.A., et al., 1992. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis, 13, 1143–1153.
  • De Jesus, V.R., et al., 2020. Urinary biomarkers of exposure to volatile organic compounds from the population assessment of tobacco and health study Wave 1 (2013–2014). International journal of environmental research and public health, 17 (15), 5408.
  • Eckert, E., et al., 2011. Mercapturic acids as metabolites of alkylating substances in urine samples of German inhabitants. International journal of hygiene and environmental health, 214 (3), 196–204.
  • EPA 2002. Health Assessment Of 1,3-Butadiene. Washington, DC: U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment.
  • Espenship, M.F., et al., 2019. Nitromethane exposure from tobacco smoke and diet in the U.S. population: NHANES, 2007–2012. Environmental science & technology, 53 (4), 2134–2140.
  • Etemadi, A., et al., 2020. Opiate and tobacco use and exposure to carcinogens and toxicants in the golestan cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the american association for cancer research, cosponsored by the american society of preventive oncology, 29 (3), 650–658.
  • FDA, 2012. Harmful and potenrially harmful constituents in tobacco products and tobacco smoke; established list. Rockville, MD: U.S. Food and Drug Administration. Federal Register.
  • Fowles, J., and Dybing, E., 2003. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco control, 12 (4), 424–430.
  • Frigerio, G., et al., 2020. Urinary biomonitoring of subjects with different smoking habits. Part I: profiling mercapturic acids. Toxicology letters, 327, 48–57.
  • Gallego, E., et al., 2018. Outdoor air 1,3-butadiene monitoring near a petrochemical industry (Tarragona region) and in several Catalan urban areas using active multi-sorbent bed tubes and analysis through TD-GC/MS. The science of the total environment, 618, 1440–1448.
  • Haussmann, H.J., 2012. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chemical research in toxicology, 25 (4), 794–810.
  • Hendler, A.H., et al., 2010. Long-term trends in ambient air 1,3-butadiene levels in Houston, Texas. Environmental science & technology, 44 (19), 7383–7390.
  • HHS, 2014. The health consequences of smoking: 50 years of progress. A report of the surgeon genera. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  • Huang, X., et al., 2020. Characteristics and health risk assessment of volatile organic compounds (VOCs) in restaurants in Shanghai. Environmental science and pollution research international, 27 (1), 490–499.
  • Huff, J.E., et al., 1985. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science (New york, N.Y.), 227 (4686), 548–549.
  • IARC, 2004. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, 83, 1–1438.
  • IARC 2008., IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). Lyon, France: IARC Monographs on the Evaluation of Carcinogenic risks to Humans.
  • Keith, R.J., et al., 2020. Characterization of volatile organic compound metabolites in cigarette smokers, electronic nicotine device users, dual users, and nonusers of tobacco. Nicotine & tobacco research : official journal of the society for research on nicotine and tobacco, 22 (2), 264–272.
  • Lechner, M., et al., 2006. Gender and age specific differences in exhaled isoprene levels. Respiratory physiology & neurobiology, 154 (3), 478–483.
  • Lin, Y.S., et al., 2001. Human physiologic factors in respiratory uptake of 1,3-butadiene. Environmental health perspectives, 109 (9), 921–926.
  • McNeal, T.P., and Breder, C.V., 1987. Headspace gas chromatographic determination of residual 1,3-butadiene in rubber-modified plastics and its migration from plastic containers into selected foods. Journal - association of official analytical chemists, 70 (1), 18–21.
  • Melnick, R.L., et al., 1990. Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations. Cancer research, 50 (20), 6592–6599.
  • Murphy, S.E., et al., 2018. Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers. NPJ precision oncology, 2, 17.
  • NTP, 1984. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). National toxicology program technical report series, 288, 1–111.
  • NTP, 1993. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). National toxicology program technical report series, 434, 1–389.
  • OSHA 1996. Occupational exposure to 1,3-butadiene. Washington, DC: U.S. Department of Labor.
  • OSHA 2012. Safety and health topics: 1,3-butadiene. Washington, DC: U.S. Department of Labor.
  • Pazo, D.Y., et al., 2016. Mainstream smoke levels of volatile organic compounds in 50 U.S. domestic cigarette brands smoked with the ISO and Canadian intense protocols. Nicotine & tobacco research, 18 (9), 1886–1894.
  • Pirkle, J.L., 1996. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA: the journal of the American medical association, 275 (16), 1233–1240.
  • Pluym, N., et al., 2015. Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methods. Analytical and bioanalytical chemistry, 407 (18), 5463–5476.
  • Richardson, K.A., et al., 1998. Identification of novel metabolites of butadiene monoepoxide in rats and mice. Chemical research in toxicology, 11 (12), 1543–1555.
  • Richardson, K.A., et al., 1999. Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicological sciences : an official journal of the society of toxicology, 49 (2), 186–201.
  • Roethig, H.J., et al., 2009. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine & tobacco research : official journal of the society for research on nicotine and tobacco, 11 (10), 1216–1225.
  • Schettgen, T., et al., 2009. A method for the quantification of biomarkers of exposure to acrylonitrile and 1,3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry. Analytical and bioanalytical chemistry, 393 (3), 969–981.
  • Shields, P.G., et al., 1995. Mutagens from heated Chinese and U.S. cooking oils. Journal of the national cancer institute, 87 (11), 836–841.
  • Smith, C.J., et al., 2000. “IARC group 2A Carcinogens” reported in cigarette mainstream smoke. Food and chemical toxicology : an international journal published for the British industrial biological research association, 38 (4), 371–383.
  • Soeteman-Hernandez, L.G., et al., 2013. Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction. Toxicological sciences, 136, 566–580.
  • St Helen, G., et al., 2014. Intake of toxic and carcinogenic volatile organic compounds from secondhand smoke in motor vehicles. Cancer epidemiology, biomarkers & prevention : a publication of the american association for cancer research, cosponsored by the American society of preventive oncology, 23 (12), 2774–2782.
  • Tevis, D. S., et al., submitted. Harmonization of acronyms for volatile organic compound metabolites using a standardized naming system. Submitted for Publication in International journal of hygiene and environmental health.
  • Urban, M., et al., 2003. Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. Journal of chromatography b, 796 (1), 131–140.
  • Watts, R.R., et al., 1990. Cotinine analytical workshop report: consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environmental health perspectives, 84, 173–182.
  • WHO, 2017. WHO report on the global tobacco epidemic. Geneva, Switzerland: World Health Organization.
  • Xiong, Y., et al., 2020. Ambient volatile organic compounds (VOCs) in two coastal cities in western Canada: Spatiotemporal variation, source apportionment, and health risk assessment. The science of the total environment, 706, 135970.
  • Yurawecz, M.P., et al., 1976. Determination of hexachloro-1,3-butadiene in spinach, eggs, fish, and milk by electron capture gas-liquid chromatography. Journal - Association of official analytical chemists, 59 (3), 552–561.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.